Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

First Time in Human Study of Intravenous Interleukin-18 Antibody (A18110040)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline
ClinicalTrials.gov Identifier:
NCT01035645
First received: December 17, 2009
Last updated: November 20, 2016
Last verified: November 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2012
  Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):